OCMF 2023
Access the 2023 Conference recording on VuMedi
Distinguished Keynote Speakers
Angela Belcher, PhD
Topic: Developing Tools to Detect Millimeter and Sub-millimeter Ovarian and Fallopian Tumors-Towards Early Detection and Interception of Ovarian Cancer
Institute for Integrative Cancer Research
George Coukos, MD, PhD
Topic: Advancing Immunotherapy in Ovarian Cancer
University of Lausanne
2023 Speakers
Developing Tools to Detect Millimeter and Sub-millimeter Ovarian and Fallopian Tumors-Towards Early Detection and Interception of Ovarian Cancer Featured Keynote: Angela Belcher, PhD Koch Institute for Integrative Cancer Research The Role Of The Extracellular Matrix In Ovarian Cancer Sandra Orsulic, PhD University of California, Los Angeles Housing temperature as a new model for studying the impact of chronic adrenergic stress on tumor growth and anti-tumor immunity Elizabeth Repasky, PhD Roswell Park Comprehensive Cancer Center Molecular Mechanisms Which Regulate Fitness Fingerprints Between Cancer and its Microenvironment Esha Madan, PhD Virginia Commonwealth University The DOD OCRP Ovarian Cancer Academy: Early Career Investigators Making a Difference in Ovarian Cancer Research Kenneth Nephew, PhD Indiana University CDON: A potential therapeutic vulnerability in ovarian cancer Denise Connolly, PhD Fox Chase Cancer Center Combining DNA methyltransferase inhibitors with platinum as a strategy to prevent recurrent ovarian cancer Heather O'Hagan, PhD Indiana University Targeting mitochondrial vulnerabilities for cancer therapy Evripidis Gavathiotis, PhD Albert Einstein College of Medicine Intra-Tumoral Nerves in Immunosurveillance Sebastien Talbot, PhD Queen’s University, Ontario Beyond Darwin: Understanding Cancer Persister Cells Yaara Oren, PhD School of Medicine, Tel Aviv University Cytomegalovirus (CMV) and Patient-Reported Outcomes in Ovarian Cancer Rachel Vogel, PhD University of Minnesota
Advancing Immunotherapy in Ovarian Cancer Featured Keynote: George Coukos, MD, PhD University of Lausanne Tubal Immune Milieu and Tumor Precursor Evolution in the Development of High-Grade Serous Carcinoma Thing Soong, MD, PhD University of Pittsburgh Susceptibility Genes in the Less Common Histotypes of Epithelial Ovarian Cancer Susan Ramus, PhD University of New South Wales Engineered Bacteria for Cancer Therapy Tal Danino, PhD Columbia University Replication Driven Vulnerabilities In Cyclin E Overexpressing Ovarian Cancers Priyanka Verma, PhD Washington University, School of Medicine Role of ZNF217 in Ovarian Cancer Metastasis Achuth Padmanabhan, PhD University of Maryland, Baltimore County Progesterone: Ovarian and Breast Cancer in BRCA1 Carriers Jaeyeon Kim, DVM, PhD, MS Indiana University, School of Medicine Targeting immune vulnerabilities and heterogeneity in ovarian cancer Dmitriy Zamarin, MD, PhD Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai Targeting the Damaged Transcriptome as an Emergent Vulnerability in Ovarian Cancer Robert Rottapel, MD University of Toronto Novel ADC’s in Ovarian Cancer Stephanie Lheureux, MD, PhD UNH Toronto Combinatorial Therapies For Ovarian Cancer Treatment Joyce Liu, MD, MPH Dana Farber Cancer Institute
Photos
